论文部分内容阅读
其他抗生素的研究进展和评价 除β-内酰胺抗生素外,其他抗生素的研究也有进一步的发展,某些方面虽然只是初步的研究,在不久的将来可能成为很重要的研究内容,现着重最近的动态分述于后。 一、氨基糖苷类: Habekacin(HBK)是一个半合成衍生物,具有以下结构: Habekacin(HBK) HBK为日本微生物化学研究所合成,明治制果公司进行开发研究的新的氨基糖苷抗生素,它具有以下特点:
Other antibiotics research progress and evaluation In addition to β-lactam antibiotics, the study of other antibiotics also have further development, although some are only preliminary studies, in the near future may become very important research content, the most recent dynamic Divided in the post. 1. Aminoglycosides: Habekacin (HBK) is a semi-synthetic derivative with the following structure: Habekacin (HBK) HBK is a new aminoglycoside antibiotic developed by the Japan Institute of Microbiology and developed by Meiji Seiyaku Co., Ltd., which has The following features: